Work

Efficacy and Safety of Eribulin Compared with Treatment of Physician’s Choice (TPC) in Patients with Advanced Non-Small-Cell Lung Cancer (NSCLC): Results from a Phase 3 Study

Year: 2014

Type: article

Source: International Journal of Radiation Oncology*Biology*Physics

DOI: 10.1016/j.ijrobp.2014.09.037

Authors: D.R. Spigel, F. Barlesi, E. Felip, J. Kim, M. Olivo, H. Nokihara, J.C. Yang, M. Satouchi, N. Katakami, N. Iannotti

Institutions: Sarah Cannon, Aix-Marseille Université, Assistance Publique Hôpitaux de Marseille, Vall d'Hebron Hospital Universitari, Yonsei University Health System, Yonsei Cancer Hospital, Eisai (United States), National Cancer Center Hospital, National Taiwan University Hospital, Hyogo Prefectural Cancer Center, Foundation for Biomedical Research and Innovation

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2330215181

FWCI: 0.534

Cites:

Cited by: 2

Related to: 10